Carboplatin Injection (Qilu) – Wholesale & Retail (For Research Use Only)

$6.00

Carboplatin Injection (Qilu) supplies 100?mg freeze?dried vials for reconstitution. Produced by Qilu Pharmaceutical Co., Ltd., licensed under H10920028 and designed for laboratory research into DNA?alkylation, tumor cytotoxicity assays, chemotherapy resistance studies, and pharmacokinetic modeling. Supports both wholesale and retail. Strictly for research use only.?For wholesale prices, other specifications and uses, please consult our staff?

Compare

描述

Carboplatin is a second?generation platinum compound that forms DNA crosslinks to inhibit cell division. It offers a more favorable toxicity profile compared to cisplatin. In oncology research, Carboplatin Injection (Qilu) is utilized to model DNA damage response, drug resistance in cancer cells, renal-cleared exposure protocols (via area-under-curve dosing), and combination oncology assays. The product is supplied as 0.1?g freeze?dried powder per vial in packs of six. For laboratory research only.

Contents hide

1 Product Specifications

2 Mechanism of Action & Research Applications

3 Side Effects (For Reference Only in Research Models)

4 Disclaimer

Product Specifications

Parameter	Detail
Product Name	Carboplatin Injection (Qilu)
Strength	0.1?g per vial (lyophilized powder)
Packaging	6 vials per box
Dosage Form	Freeze?dried powder for injection
Manufacturer	Qilu Pharmaceutical Co., Ltd.
Approval Number	???? H10920028
Drug Standard Code	86904021000295
Barcode	6915798003635
CAS Number	41575?94?4
Molecular Formula	C?H??N?O?Pt

Mechanism of Action & Research Applications

Carboplatin induces intra- and inter-strand DNA cross-linking, preventing DNA replication and triggering apoptosis. It is widely used in laboratory research to study tumor cytotoxicity, DNA repair mechanisms, pharmacokinetics modeling (e.g., AUC-based dosing), and drug-resistance assays, including combination chemotherapy protocols. It’s particularly valuable for translation models of platinum chemistry in oncology research.

Side Effects (For Reference Only in Research Models)

Based on clinical-analog data, potential responses include bone marrow suppression (thrombocytopenia, neutropenia, anemia), mild nausea, fatigue, and possible allergic reactions. Carboplatin is notably less nephrotoxic than cisplatin, but caution is advised when designing dosing protocols, especially with renal clearance considerations.

Disclaimer

Carboplatin Injection (Qilu) is strictly intended for laboratory research use only. Not for human or veterinary therapeutic or diagnostic use.

其他信息

重量	0.6 公斤
尺寸	23 × 36 × 23 厘米

评价

目前还没有评价

成为第一个“Carboplatin Injection (Qilu) – Wholesale & Retail (For Research Use Only)” 的评价者

Q1: What is Carboplatin Injection (Qilu) used for in research?

A: Carboplatin Injection (Qilu) is used to model DNA damage response, simulate anticancer cytotoxic protocols, and study chemotherapeutic resistance in oncology laboratory assays.

Q2: How does Carboplatin Injection (Qilu) work in experimental models?

A: It crosslinks DNA to inhibit replication and induce apoptosis. Laboratory dosing can be calibrated using AUC-based pharmacokinetic models to mimic clinical exposure levels.

Q3: Why choose Carboplatin Injection (Qilu) for research?

A: The product is manufactured under regulatory approval (H10920028) by an established manufacturer (Qilu) and provides consistent purity and formulation, making it ideal for reproducible experimental use.

Q4: Which research applications commonly use Carboplatin Injection (Qilu)?

A: Common uses include DNA repair assays, tumor cell viability studies, combination chemotherapy screening, and pharmacokinetic modeling in preclinical research.

Q5: Can I order Carboplatin Injection (Qilu) in bulk?

A: Yes, wholesale and retail orders are supported. Contact us for pricing, minimum order quantity, and logistics information.

Q6: How should Carboplatin Injection (Qilu) be stored for research use?

A: Store lyophilized vials at controlled room temperature in a dry environment. Reconstituted solutions should be used immediately or stored under sterile refrigeration as per lab protocols.

Q7: Can Carboplatin Injection (Qilu) be used with other research agents?

A: Yes, it is frequently combined with taxanes, radiation models, or DNA repair inhibitors in synergy and resistance studies.

Q8: What adverse observations may appear in models using Carboplatin Injection (Qilu)?

A: Potential observations include marrow suppression, mild systemic symptoms (nausea, fatigue), and possible allergic markers; use these as reference in safety and dose guidance.

Q9: Is Carboplatin Injection (Qilu) approved for clinical use?

A: It is approved in China under licence H10920028. However, this product listing is strictly for laboratory research use only and not intended for therapeutic application.